[Federal Register Volume 61, Number 66 (Thursday, April 4, 1996)]
[Notices]
[Page 15120]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-8307]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 31, 1996,
Mallinckrodt Chemical, Inc., Mallinckrodt & Second Streets, St. Louis,
Missouri 63147, made application to the Drug Enforcement Administration
(DEA) for registration as a bulk manufacturer of the basic classes of
controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............................... I
Methylphenidate (1724)..................................... II
Cocaine (9041)............................................. II
Codeine (9050)............................................. II
Diprenorphine (9058)....................................... II
Etorphine Hydrochloride (9059)............................. II
Dihydrocodeine (9120)...................................... II
Oxycodone : 9143).......................................... II
Hydromorphone (9150)....................................... II
Diphenoxylate (9170)....................................... II
Hydrocodone (9193)......................................... II
Levorphanol (9220)......................................... II
Meperidine (9230))......................................... II
Methadone (9250)........................................... II
Methadone-intermediate (9254).............................. II
Dextropropozyphene, bulk (non-dosage forms) (9273)......... II
Morphine (9300)............................................ II
Thebaine (9333)............................................ II
Opium extracts (9610)...................................... II
Opium fluid extract (9620)................................. II
Opium tincture (9630)...................................... II
Opium powdered (9639)...................................... II
Opium granulated (9640).................................... II
Levo-alphacetylmethadol (9648)............................. II
Oxymorphone (9652)......................................... II
Noroxymorphone (9668)...................................... II
Alfentanil (9737).......................................... II
Sufentanil (9740).......................................... II
Fentanyl (9801)............................................ II
------------------------------------------------------------------------
The firm plans to produce bulk finished products for distribution
to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the above application.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, D.C. 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than June 3, 1996.
Dated: March 27, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 96-8307 Filed 4-3-96; 8:45 am]
BILLING CODE 4410-09-M